key: cord-0943730-jjnehzy4
authors: Chou, Janet; Platt, Craig D.; Habiballah, Saddiq; Nguyen, Alan A.; Elkins, Megan; Weeks, Sabrina; Peters, Zachary; Day-Lewis, Megan; Novak, Tanya; Armant, Myriam; Williams, Lucinda; Rockowitz, Shira; Sliz, Piotr; Williams, David A.; Randolph, Adrienne G.; Geha, Raif S.; Almutairi, Abduarahman; Jaber, Faris; Banzon, Tina; Roberts, Jordan; Halyabar, Olha; Lo, Mindy; Kahn, Stacy; Henderson, Lauren A.; Lee, Pui Y.; Son, Mary Beth; Cheng, Leah
title: Mechanisms underlying genetic susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C)
date: 2021-07-02
journal: J Allergy Clin Immunol
DOI: 10.1016/j.jaci.2021.06.024
sha: 08593577091ef231225063470c86220179289b9e
doc_id: 943730
cord_uid: jjnehzy4

Background Multisystem Inflammatory Syndrome in Children (MIS-C) is a pediatric complication of SARS-CoV-2 infection characterized by multiorgan inflammation and frequently, cardiovascular dysfunction. It occurs predominantly in otherwise healthy children. We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. Objectives We aimed to identify additional genetic mechanisms underlying susceptibility to SARS-CoV-2-associated MIS-C. Methods In a single center, prospective cohort study, whole exome sequencing was performed on patients with MIS-C. The impact of candidate variants was tested using patients’ peripheral blood mononuclear cells obtained at least seven months after recovery. Results We enrolled 18 patients with MIS-C (median age: 8 years, IQR 5 – 12.25 years), of whom 89% had no conditions other than obesity. In two boys with no significant infection history, we identified and validated hemizygous, deleterious defects in XIAP, encoding X-linked inhibitor of apoptosis, and CYBB, encoding cytochrome b-245. Including the previously reported SOCS1 haploinsufficiency, a genetic diagnosis was identified in three (17%) of 18 patients. Even after recovery, patients with defects in SOCS1, XIAP, or CYBB exhibit an inflammatory immune cell transcriptome with enrichment of differentially expressed genes in pathways downstream of IL-18, oncostatin M, and NF-κB, compared to those with mild COVID-19. Conclusions Although inflammatory disorders are rare in the general population, our cohort of patients with MIS-C was enriched for monogenic susceptibility to inflammation. Our results support the use of next-generation sequencing in previously healthy children who develop MIS-C.

within four weeks of symptoms, without an alternative diagnosis. 3 Since most children with MIS- patients. 4, 5 In contrast, MIS-C is not associated with pre-existing cardiopulmonary, 86 autoimmune/immune, or hematologic diseases and its genetic basis is largely unknown. 1 

We previously reported haploinsufficiency of Suppressor of Cytokine Signaling 1 88 (SOCS1), a negative regulator of Type I and II interferons, as a genetic risk factor for MIS-C. 6 

Here, we present findings from our prospective cohort sequencing study of children and Table 1) . Nearly all (89%, n=16) had no pre-existing medical conditions other than obesity in PCR testing for SARS-CoV-2 was negative on the fourth, but positive on the seventh, day of 103 illness. He had neutrophilia, T cell lymphopenia, increased levels of the T cell activation marker 104 soluble CD25, and elevated levels of IL-18, IL-6, IL-10, and C-X-C Motif Chemokine Ligand 9 105 (CXCL9) indicative of Type I and II IFN signaling ( Table 2) . He developed warm cardiogenic 106 shock in the setting of severely depressed systolic cardiac function and third-degree heart block.

He was treated with remdesivir, anakinra, methylprednisolone (2 mg/kg twice daily), intravenous 108 immunoglobulin (IVIG, 1 g/kg), and vasopressors. While on methylprednisolone, he was found 109 to have Epstein Barr virus (EBV) viremia (4.3 log 10 copies/mL). He had undetectable IgM to 110 capsid and early D antigen, consistent with EBV reactivation. His EBV viremia peaked to 6 log 10 111 copies/mL while on prednisone, and persisted at 3.9 log 10 copies/mL for nine months until it was 112 cleared by one dose of rituximab. After recovery from MIS-C, his NK cytotoxicity function was 113 found to be normal.

WES identified a novel hemizygous missense variant in XIAP (NP_001158.2: 115 p.Ser421Asn). XIAP is a widely expressed protein that contributes to cellular survival, activation, 116 and negative regulation of the NLRP3 inflammasome. 7 This variant has a minor allelic frequency 117 of 1.1 x 10 -5 in the gnomAD database and was predicted to be benign with a Combined 118 Annotation Dependent Depletion (CADD) score of 4.9. However, structural modeling predicts 119 that the variant creates a hydrogen bond with alanine 417 within the ubiquitin-associated (UBA) 120 domain, thereby potentially disrupting the domain's structure and/or capacity for binding 121 ubiquitin (Fig. 1A) . The patient exhibited intact XIAP protein expression (Fig. 1B) . The UBA 122 domain is important for TNF- secretion following nucleotide-binding oligomerization domain-123 containing (NOD) 2 activation. 7 Compared to controls, CD14 + HLA-DR + monocytes from Patient 124 J o u r n a l P r e -p r o o f 1 secreted less TNF- in response to NOD2 activation with muramyl dipeptide (Fig. 1C) , indicative of impaired XIAP function. TNF- secretion after LPS stimulation, which is lymphohistiocytosis and cytokine storm syndromes. 8 This has been attributed to loss of XIAP-129 mediated negative regulation of the NLRP3 inflammasome, which relies on the protein's 130 ubiquitylation function. 7, 9 Mice lacking either XIAP or XIAP-mediated ubiquitinylation secrete 131 increased IL-1 downstream of TLR3-or TLR4-mediated activation of the NLRP3 132 inflammasome. 9 In contrast, XIAP is not required for IL-6 or TNF- secretion after TLR 133 stimulation. 10 TLR3 binds to double-stranded viral RNA intermediates, while TLR4 binds to 134 SARS-Cov-2 spike protein. 4, 11 Compared to controls, peripheral blood mononuclear cells 135 (PBMCs) from Patient 1 secreted increased IL-1 after TLR3 and TLR4 stimulation (Fig. 1D) .

As anticipated, TNF- secretion after TLR3 or TLR4 stimulation was comparable between 137 Patient 1 and controls (Fig. 1E) . These findings show the impaired function of XIAP Ser421Asn , 138 leading to inflammatory signaling that likely predisposed this patient to MIS-C.

was healthy until three weeks prior to admission, when he developed hematochezia. He had 141 neutrophilia, CD4 + and CD8 + T cell lymphopenia, procalcitonin and CRP levels exceeding 100- (Fig. 1F) , this variant is predicted to be pathogenic with a CADD score of 31 and 160 has a minor allelic frequency of 3.9x20 -4 in gnomAD. The patient's neutrophil oxidative burst 161 was impaired, but not absent (Fig. 1G ). This contrasts with the minimal neutrophil oxidative Of the two patients with pre-existing medical conditions, one patient had sickle cell anemia and the other had Evans syndrome. # Positive SARS-CoV-2 serology was performed using either the Roche Elecsys or Viracor assays. Whole exome sequencing. Whole exome sequencing (WES) was performed by GeneDx using IDT xGen probes with an average coverage across the WES of 100x and more than 95% of targets covered at 20x, as previously described. 1 Variant calling and candidate variant analysis were completed utilizing the Boston Children's Hospital Genomic Learning System (GLS), as previously described. 1 Minor allelic frequencies for the specified variants were identified using the Genome Aggregation Database (gnomAD). 2 Single cell RNA sequencing. For each sample, approximately 17,000 PBMCs at a concentration of 1000 cells/µL were input into a 10x Genomics Chromium Controller. Chromium Next GEM Single Cell 3ʹ kits (v3.1) were used to generate single-cell gene expression libraries, which we subsequently sequenced using an Illumina NextSeq 500 system with 150 bp pairedend sequencing. Libraries were processed using CellRanger v3.1 (10x Genomics) and GrCh38 as the reference. Partek Flow was used to analyze the data output from CellRanger (data filtering, log-normalization, integration, scaling, dimensionality reduction, and cluster identification). We excluded genes expressed in fewer than 5 cells as well as those encoding ribosomal structural proteins and non-coding ribosomal RNA; 3 low quality cells with more than 10% mitochondrial gene content or fewer than 200 features were also excluded. Principal component analysis (PCA) was performed using the elbow heuristics method to determine the 15 top PCs for subsequent clustering analysis using the Louvain clustering algorithm, followed by Uniform Manifold Approximation and Projection (UMAP) visualization. Pathway analysis of differentially expressed genes within cell types was performed using Ingenuity Pathway Analysis (Qiagen Bioinformatics, Redwood City, CA, United States).

Flow cytometry. Protocols for staining of XIAP were performed as previously described. 34 For quantification of intracellular TNF-, PBMCs were rested overnight in a 48 well plate and non-adherent cells were removed the following day. Adherent PBMCs, comprised primarily of monocytes, were stimulated with lipidated muramyl dipeptide (200 ng/mL, InvivoGen, San Diego) or LPS (200 ng/mL, InvivoGen, San Diego) for 2.5 hours with brefeldin, followed by flow cytometric staining for HLA-DR + CD14 + TNF- + monocytes as previously described. 5 IL-1 secretion downstream was measured using cytometric bead array (BD Biosciences, Piscataway) per the manufacturer's protocol after PBMCs were stimulated with Poly(I:C) (10 µg/mL, InvivoGen, San Diego) or LPS (100 ng/mL, InvivoGen, San Diego) for 24 hours.

Transcriptome analysis. mRNA was isolated from PBMCs using the RNeasy Mini Kit (Qiagen), followed by cDNA synthesis using the SuperScript™ VILO™ cDNA Synthesis Kit (ThermoFisher Scientific). The Ion AmpliSeq Transcriptome Human Gene Expression Kit was used to prepare barcoded libraries and sequenced using an Ion S5 TM next-generation sequencer. The AmpliSeqRNA plugin (ThermoFisher) was used to calculate differential gene expression analysis. Pathway analysis was performed using Ingenuity Pathway Analysis and Gene Set Enrichment Analysis (Broad Institute and University of California San Diego) 6,7 on genes with at least 1.5-fold difference between controls and patients (p<0.05). Final analyses were performed using adjusted p values calculated with the Benjamini-Hochberg procedure.

Statistical analysis. All tests were two-sided, and ps<0.05 was considered significant using the indicated statistical tests. Statistical analyses were performed using Prism 8.0 software (GraphPad Software).

Distinct 221 clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory 222 syndrome in children

CDC. Multisystem Inflammatory Syndrome in Children (MIS-C) [Internet]. Centers for

Disease Control and Prevention

Inborn errors of type I

Children's rare disease cohorts: an integrative research and clinical genomics initiative

The mutational constraint spectrum quantified from variation in 141,456 humans

RPG: the Ribosomal Protein Gene database

A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency

A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes